Uncategorized


November 13, 2025

(NVDA, MSFT, GOOGL, AMZN, META) AI Sector: Federal Pre-emption of State Law Unlikely for Now

By Joe Lieber

We continue to believe that efforts to prevent states and localities from enforcing AI-specific laws or regulations for up to 10 years is unlikely to become federal law for at least the duration of President…

Read More >>

November 10, 2025

Capitol Policy Weekly: Government Shutdown, Stimulus, ACA Subsidies, Syria and Ukraine

By Joe Lieber

Both the House and Senate will very likely be in session this week, with the government shutdown seemingly on the verge of ending later this week. In addition, President Trump has reiterated his desire to…

Read More >>

November 9, 2025

Obamacare HIX Fix: HSAs for All or Compromise on Subsidy Changes? We Still Think the Latter [OSCR, CNC, ELV, MOH, UNH, HQY, WBS, EHTH]

By Beth Steindecker

President Trump’s Truth Social posts over the weekend, along with that of other Republicans, suggest an existential threat for Obamacare insurers [OSCR, CNC, ELV, MOH, UNH] and potentially other commercial health insurers [CI, CVS] while…

Read More >>

November 7, 2025

Obesity Drug Pricing Deal: Devil in the Details

By John Leppard

As outlined by the Trump administration, we view yesterday’s obesity drug pricing deal with NVO and LLY as a modest near-term positive (potentially better for LLY), with the $245 / mo. price point for Medicare…

Read More >>

November 6, 2025

(NVDA) Nvidia’s Blackwell Chips and the China Trade Outlook

By Joe Lieber

With Nvidia (NVDA) exports to China once again making headlines, we see roughly a 40–50% probability that the company will be permitted to export China-specific versions of its Blackwell chips as early as next year. …

Read More >>

November 5, 2025

Medicare Advantage: Still Expecting Light Regulatory Touch for CY27 [HUM, ALHC, AGL, UNH, CVS, ELV, CNC, PRVA]

By Beth Steindecker

Listening to recent earnings calls held by various Medicare Advantage (MA) insurers and value-based care providers [HUM, ALHC, AGL, UNH, CVS, ELV] leaves us with the following thoughts on the MA regulatory policy environment for…

Read More >>

November 5, 2025

[LLY, NVO] Obesity Rx Deal Expectations

By John Leppard

Following reports yesterday [here, here] that the White House may announce an agreement with LLY and NVO as early as tomorrow to make obesity products available for $149 / month, “in return for coverage” under…

Read More >>

November 4, 2025

IEEPA at the Supreme Court: The Stakes for Trump’s Tariff Strategy

By Joe Lieber

We continue to give ~60% odds that the Trump administration sees a partial loss in the International Emergency Economic Powers Act (IEEPA) case, which will be argued before the Supreme Court (SCOTUS) tomorrow. However, as…

Read More >>

November 3, 2025

[MDXG, CTEC.LN, COLOB.C] Skin Substitute Rates & Additional Risks

By John Leppard

Consistent with our expectations, we view MDXG and CTEC.LN as most exposed to CMS’s finalized Physician Fee Schedule (PFS) policy to reduce skin substitute payments from current Average Sales Price (ASP) / invoice levels to…

Read More >>

November 3, 2025

Physicians: Final Rule Favors Independent Doctors / Freestanding Centers but Cost Growth and Rate Pressures on Facility-Based Doctors Remain [RDNT, USPH, SEM, PRVA, ASTH, RadPar, Envision]

By Beth Steindecker

CMS’s final CY26 Medicare Physician Fee Schedule (PFS), released late Friday, offered a split-screen picture for physicians, largely depending on whether they provide care in the office / freestanding center (positive) or in a facility…

Read More >>